Woebot

نقاط القوة

• +Woebot earns a Good rating in psychiatry as a patient-facing digital therapeutic rather than a clinician tool. Its Stanford-developed CBT approach and FDA Breakthrough Device Designation are notable, though the narrow therapeutic scope limits broader clinical utility.
• +FDA Breakthrough Device Designation for adolescent depression
• +Evidence-based CBT, DBT, and interpersonal psychotherapy techniques
• +Developed at Stanford with peer-reviewed RCT evidence
• +Addresses the 31,000-psychiatrist workforce shortage by scaling access
• +Available 24/7 — extends therapeutic support between appointments

القيود

• –Patient-facing tool, not a clinical decision support platform for psychiatrists
• –No psychopharmacology support, drug interaction checking, or monitoring protocols
• –Cannot diagnose conditions or prescribe دواءs
• –No EHR integration for clinician workflows
• –Limited to structured therapeutic exercises — not a replacement for therapy